New hope for lymphoma patients: personalized treatment targets cancer without chemo
NCT ID NCT06793189
First seen Apr 08, 2026 · Last updated May 18, 2026 · Updated 5 times
Summary
This study tests a personalized treatment approach for people with untreated marginal zone lymphoma, a slow-growing blood cancer. About 145 participants will receive targeted therapy based on their individual risk score. The goal is to see if this tailored treatment can keep the cancer from coming back for at least two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA(MZL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, China
Contact Email: •••••@•••••
-
Peking University Third Hospital
RECRUITINGBeijing, China
Contact Email: •••••@•••••
-
Shanghai Ruijin Hospital
RECRUITINGShanghai, China, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.